Project Grant S10OD040266
- Federal Project Grant Award Summary The University of Rochester received a $923,205 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and implement a VEVO F2-LAZR-X ultrasound and photoacoustic imaging system. The award, effective from August 1, 2025, through July 31, 2026, provides a state-of-the-art multi-modal imaging platform capable of conducting real-time in vivo imaging in small...
- Federal Grant Award Summary The University of Rochester received a $350,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a bulk Gruenberg dry heat sterilizer for its biomedical research facilities. The equipment is designed to double the sterile mouse cage throughput capacity across the university's two vivaria—the Kornberg Medical Research Building (KMRB) and the School of Medicine...
- Federal Grant Award Summary The University of Rochester received a $466,325 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker Skyscan 1276 CMOS Edition high-resolution micro-computed tomography (microCT) imaging system. The award, effective May 15, 2026 through May 14, 2027, funds the procurement and installation of this advanced imaging instrument to replace obsolete 21-year-old...
- Federal Grant Award Summary The University of Rochester received a $415,250 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 7, 2025, with a completion date of June 30, 2027. The award supports investigator-initiated biomedical research focused on understanding the immunological mechanisms of viral respiratory infections, specifically examining how long-lived highly differentiated...
- Federal Project Grant Award Summary The University of Rochester received a $249,000 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2028. This award funds research to advance understanding of adenylyl cyclase (AC) signaling, a critical mechanism in cellular communication that regulates numerous physiological processes. The research will deliver structural and...
- Federal Grant Award Summary The University of Rochester received a $464,133 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113), with an award date of August 5, 2025, and completion date of July 31, 2027. The project, titled "Cell Specific Proteomics Highlights Molecular Signatures of Manganese Neurotoxicity in Dopaminergic Neurons in Vivo," investigates the molecular mechanisms by which manganese...
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded the University of Rochester a $716,066 Project Grant on September 19, 2025, under the Environmental Health program (CFDA 93.113) to investigate the mechanisms of environmentally-induced bronchiolitis obliterans (BO). This devastating lung disease of the small airways is increasingly associated with occupational inhalation exposures to reactive diketone chemicals, particularly...
- Federal Grant Award Summary The University of Rochester received a $906,000 Project Grant from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113), awarded February 19, 2026, with completion targeted for January 31, 2034. This research initiative investigates the mechanisms by which environmental tobacco smoke (ETS) and cigarette smoke exposure disrupts molecular clock function—specifically the nuclear receptor REV-ERBA—resulting...
- Federal Project Grant Award Summary The University of Rochester received a $414,159 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award supports fundamental research investigating how eukaryotic cells employ differential stress response mechanisms to adapt to physiological challenges. The research focuses on understanding how cells...
- Federal Grant Award Summary The University of Rochester received a $226,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025 through June 30, 2027. This award funds research investigating novel mechanisms of CD4-independent immunity against Pneumocystis pneumonia (PCP), a life-threatening fungal respiratory infection affecting immunocompromised patients. The...
The University of Rochester received a $145,400 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on June 15, 2026, with completion anticipated by June 14, 2027. This award supports the acquisition and integration of an ultrafine particle generator and scanning mobility particle sizer integrated system for the university's Inhalation Exposure Facility (IEF). The equipment will advance the institution's long-established inhalation toxicology research capabilities by enabling controlled generation and characterization of ultrafine particles (UFP), supporting studies on how airborne pollutants contribute to cumulative health risks across the lifespan. The Research Infrastructure Programs funds specialized scientific instrumentation and equipment modernization essential to the biomedical research enterprise. This award directly supports the University of Rochester's basic and translational research mission by providing critical infrastructure to study the effects of ambient air pollution—a significant public health threat—and assess how airborne substances, alone or in combination with other stressors, impact human health through inhalation exposure pathways.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $145.4k | 6/19/26 |